Lisa Scholz interviewed HRSA's OPA Director Chantelle Britton at the MDRP Summit in Chicago.

Exclusive

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.